These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 30213491

  • 1. Sex-specific and lasting effects of a single course of antenatal betamethasone treatment on human placental 11β-HSD2.
    Braun F, Hardt AK, Ehrlich L, Sloboda DM, Challis JRG, Plagemann A, Henrich W, Braun T.
    Placenta; 2018 Sep; 69():9-19. PubMed ID: 30213491
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of placental 11β-HSD2 induced by high maternal glucocorticoid exposure mediates sex differences in placental and fetal development.
    Yu P, Zhou J, Ge C, Fang M, Zhang Y, Wang H.
    Sci Total Environ; 2022 Jun 25; 827():154396. PubMed ID: 35259391
    [Abstract] [Full Text] [Related]

  • 3. Sex-specific alterations in placental 11beta-hydroxysteroid dehydrogenase 2 activity and early postnatal clinical course following antenatal betamethasone.
    Stark MJ, Wright IM, Clifton VL.
    Am J Physiol Regul Integr Comp Physiol; 2009 Aug 25; 297(2):R510-4. PubMed ID: 19535674
    [Abstract] [Full Text] [Related]

  • 4. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants.
    Kajantie E, Dunkel L, Turpeinen U, Stenman UH, Andersson S.
    Pediatr Res; 2006 Apr 25; 59(4 Pt 1):575-8. PubMed ID: 16549532
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antenatal exposure to betamethasone induces placental 11β-hydroxysteroid dehydrogenase type 2 expression and the adult metabolic disorders in mice.
    Ni L, Pan Y, Tang C, Xiong W, Wu X, Zou C.
    PLoS One; 2018 Apr 25; 13(9):e0203802. PubMed ID: 30212527
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J, Guan H, Sampath-Kumar R, Richardson BS, Yang K.
    Placenta; 2008 Feb 25; 29(2):193-200. PubMed ID: 18061258
    [Abstract] [Full Text] [Related]

  • 10. Differences in expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender.
    Mericq V, Medina P, Kakarieka E, Márquez L, Johnson MC, Iñiguez G.
    Eur J Endocrinol; 2009 Sep 25; 161(3):419-25. PubMed ID: 19542242
    [Abstract] [Full Text] [Related]

  • 11. Growth restricting effects of a single course of antenatal betamethasone treatment and the role of human placental lactogen.
    Braun T, Husar A, Challis JR, Dudenhausen JW, Henrich W, Plagemann A, Sloboda DM.
    Placenta; 2013 May 25; 34(5):407-15. PubMed ID: 23465880
    [Abstract] [Full Text] [Related]

  • 12. Species differences of 11beta-hydroxysteroid dehydrogenase type 2 function in human and rat term placenta determined via LC-MS/MS.
    Heussner K, Ruebner M, Huebner H, Rascher W, Menendez-Castro C, Hartner A, Fahlbusch FB, Rauh M.
    Placenta; 2016 Jan 25; 37():79-84. PubMed ID: 26654513
    [Abstract] [Full Text] [Related]

  • 13. A heretical view: rather than a solely placental protective function, placental 11β hydroxysteroid dehydrogenase 2 also provides substrate for fetal peripheral cortisol synthesis in obese pregnant ewes.
    Ghnenis AB, Odhiambo JF, Smith AM, Pankey CL, Nathanielsz PW, Ford SP.
    J Dev Orig Health Dis; 2021 Feb 25; 12(1):94-100. PubMed ID: 32151296
    [Abstract] [Full Text] [Related]

  • 14. Foetal and placental 11β-HSD2: a hub for developmental programming.
    Cottrell EC, Seckl JR, Holmes MC, Wyrwoll CS.
    Acta Physiol (Oxf); 2014 Feb 25; 210(2):288-95. PubMed ID: 24330050
    [Abstract] [Full Text] [Related]

  • 15. Reconciling the nutritional and glucocorticoid hypotheses of fetal programming.
    Cottrell EC, Holmes MC, Livingstone DE, Kenyon CJ, Seckl JR.
    FASEB J; 2012 May 25; 26(5):1866-74. PubMed ID: 22321728
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. nAChRs-ERK1/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11β-HSD2.
    Zhou J, Liu F, Yu L, Xu D, Li B, Zhang G, Huang W, Li L, Zhang Y, Zhang W, Wang H.
    Toxicol Appl Pharmacol; 2018 Apr 01; 344():1-12. PubMed ID: 29486207
    [Abstract] [Full Text] [Related]

  • 19. Effects of maternal dexamethasone treatment in early pregnancy on pituitary-adrenal axis in fetal sheep.
    Braun T, Li S, Sloboda DM, Li W, Audette MC, Moss TJ, Matthews SG, Polglase G, Nitsos I, Newnham JP, Challis JR.
    Endocrinology; 2009 Dec 01; 150(12):5466-77. PubMed ID: 19846612
    [Abstract] [Full Text] [Related]

  • 20. Maternal betamethasone administration reduces binucleate cell number and placental lactogen in sheep.
    Braun T, Li S, Moss TJ, Newnham JP, Challis JR, Gluckman PD, Sloboda DM.
    J Endocrinol; 2007 Aug 01; 194(2):337-47. PubMed ID: 17641283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.